When medical marijuana became legal in Massachusetts, she encouraged caregivers to try it in dementia patients with agitation ...

The FDA has approved Auvelity for treating agitation in patients with dementia due to Alzheimer’s disease, Axsome ...

A new study led by researchers at UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has identified potential biological ...

The progressive brain disorder causes symptoms similar to Parkinson's disease in addition to memory and cognitive declines.

New research into nursing home care for residents living with Alzheimer’s disease or related dementias found that they frequently experience costly and burdensome treatments that do not align with ...

US FDA approves Axsome Therapeutics’ Auvelity to treat agitation associated with dementia due to Alzheimer’s disease: New York Monday, May 4, 2026, 12:30 Hrs [IST] Axsome Ther ...

Finger-prick blood test alongside online thinking test could flag people with early memory problems which could become ...

An Icelandic scaleup has sparked hopes of a breakthrough in dementia treatment after raising €26.5mn for groundbreaking research. Arctic Therapeutics (ATx) attracted the investment after pioneering a ...

A center sharing the most up-to-date treatments and techniques for the challenges of dementia for patients and their doctors, ...

Ted Turner was diagnosed with Lewy body dementia years before his death at 87. What to know about the symptoms and treatment ...

FDA cleared the first agent with an NMDA/sigma-1–based mechanism specifically for agitation in Alzheimer’s disease dementia, ...

A finger prick blood test combined with online brain testing—all done from home—could one day effectively identify people's ...